SI
SHOULDER INNOVATIONS, INC.
NYSE · Healthcare · Medical - Specialties · US
$20.32
−0.34%Income statement
| Metric | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | 60.1M | 47.3M | 31.6M | 19.3M |
| Cost of Revenue | 13.6M | 11.1M | 7.3M | 4.0M |
| Gross Profit | 46.4M | 36.2M | 24.3M | 15.3M |
| Operating Expenses | ||||
| R&D Expense | 11.9M | 7.7M | 4.5M | 3.0M |
| SG&A Expense | 69.7M | 54.8M | 34.5M | 23.1M |
| General & Admin Expense | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — |
| Other Expenses | — | — | — | — |
| Total Operating Expenses | 81.6M | 62.5M | 39.0M | 26.1M |
| Cost and Expenses | 95.2M | 73.6M | 46.3M | 30.1M |
| Operating Income (EBIT) | (35.2M) | (26.3M) | (14.7M) | (10.9M) |
| Non-Operating | ||||
| Interest Income | 673.0K | — | — | — |
| Interest Expense | (949.0K) | 70.0K | 1.3M | 761.0K |
| Net Interest Income | 1.6M | (70.0K) | (1.3M) | (761.0K) |
| Other Non-Op Income/Expense | 120.0K | (14.1M) | (966.0K) | (1.8M) |
| Non-Operating Income (excl Interest) | 829.0K | 14.0M | (350.0K) | 1.0M |
| EBT (Pre-Tax Income) | (35.0M) | (40.4M) | (15.6M) | (12.7M) |
| Income Tax Expense | — | — | — | — |
| Bottom Line | ||||
| Net Income | (35.0M) | (40.4M) | (15.6M) | (12.7M) |
| Earnings from Cont. Ops | (35.0M) | (40.4M) | (15.6M) | (12.7M) |
| Earnings from Discont. Ops | — | — | — | — |
| Bottom Line Net Income | (35.0M) | (40.4M) | (15.6M) | (12.7M) |
| Per Share | ||||
| Basic EPS | ($1.71) | ($1.96) | ($0.77) | ($0.63) |
| Diluted EPS | ($1.71) | ($1.96) | ($0.77) | ($0.63) |
| Revenue Per Share | $2.90 | $2.29 | $1.59 | $0.97 |
| Shares | ||||
| Basic Shares Outstanding | 20.7M | 20.6M | 19.9M | 19.9M |
| Diluted Shares Outstanding | 20.7M | 20.6M | 19.9M | 19.9M |
| Profitability Metrics | ||||
| EBITDA | (33.0M) | (37.1M) | (12.1M) | (10.3M) |
| D&A | 3.0M | 3.2M | 2.2M | 1.6M |
| EBIT | (36.0M) | (40.3M) | (14.3M) | (11.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026